$VEEVBullishMed

10 Best SaaS Stocks to Buy According to Hedge Funds

The article says SaaS stocks fell in 2026 amid AI disruption fears, citing IBM’s 10.3% drop and ServiceNow’s nearly 15% drop on April 23 despite Q1 revenue/profit beats and ServiceNow’s Middle East deal delays. It notes a May 19 rebound in Workday, ServiceNow and Salesforce. Using Insider Monkey Q1 2026 data, it lists Veeva (62 funds, $2.95B) and Autodesk (67 funds, $3.17B), including Autodesk’s $3.6B MaintainX deal and raised FY27 guidance.

Med
Bullish
after-hours/this week context (deal + Q1 results referenced; article published May 30)
Fits a selective SaaS risk-on tone after May 19 rally, but notes broader AI-disruption fears persist.

New customer/platform deployments and product expansion support revenue visibility in life-sciences SaaS, with incremental upside tied to enterprise adoption.

Veeva announced Kindeva adoption of Veeva Quality Cloud plus new global CRM commitments and an agentic platform rollout for life-sciences workflows.

Mild-to-moderate positive bias; likely supports dip-buying rather than a standalone breakout catalyst.

Background

The article frames 2026 as a choppy SaaS tape amid AI disruption fears, then highlights hedge-fund positioning and specific company catalysts for two of the listed names (Veeva and Autodesk).

Why it matters

VEEV’s impact is tied to enterprise life-sciences platform expansion (Quality Cloud, Vault CRM commitments, and agentic Falcon). ADSK’s impact is tied to a large M&A transaction (MaintainX) plus raised fiscal guidance, partially offset by a sell-side price-target reduction citing acquisition multiple concerns.

Market relevance

Actionable catalysts exist for ADSK (M&A + raised guidance) and VEEV (new enterprise deployments and product expansion), while the rest of the article is largely positioning/selection methodology.

Market effects

Highlights hedge-fund preference for SaaS names with embedded workflows and enterprise switching potential, contrasting with AI-disruption/structural-headwind narratives.

Limited direct regional impact; one Veeva deal is global and Autodesk deal is US-listed, with no specific regional macro shock cited.

Life-sciences digitization and enterprise maintenance software remain global themes; deal and CRM commitments suggest continued cross-region enterprise spend.

Alternative perspectives

The piece is a hedge-fund “best picks” roundup; for trading, the real edge is the specific Veeva customer/platform announcements and Autodesk’s MaintainX deal, not the broader sentiment framing.

For ADSK, the acquisition’s multiple and integration execution risk may matter more than the raised guidance; for VEEV, deal timing and adoption ramp (not just announcements) will drive near-term results.

Key entities

  • Veeva Systems

    Life-sciences cloud software provider; announced Kindeva adoption of Veeva Quality Cloud and additional global CRM commitments, plus an agentic platform (Falcon).

  • Autodesk

    Design/engineering software firm; agreed to acquire MaintainX for $3.6B and raised fiscal 2027 outlook after Q1 results.

  • MaintainX

    Maintenance and operations software firm to be acquired by Autodesk; expected >$135M annualized recurring revenue for 2026.

  • Wells Fargo

    Lowered its Autodesk price target to $330 from $350 while keeping an Overweight rating.

Related articles

$ADSKMed

Autodesk CFO Says MaintainX Deal Extends AI Push Across Asset Lifecycle

Autodesk CFO said the MaintainX acquisition will extend its AI push across the asset lifecycle, pairing MaintainX’s operational data from about 14,000 customers and 10 million assets with Autodesk’s design and construction data. He said MaintainX is not driven by core-demand concerns; Autodesk expects fiscal 2024-26 resilience. Autodesk plans $2 billion in new debt for the deal and targets unchanged fiscal 2027 and 2029 operating margin goals, with 2029 at 41% non-GAAP.

$DDOGMed

Stocks Retreat as US-Iran Peace Hopes in Doubt

US stocks retreated as markets scaled back hopes for US-Iran peace. US MBA mortgage applications fell 2.5% (purchase -2.9%, refi -2.3%); the 30-year fixed rate dropped 8 bp to 6.57%. The Fed Beige Book was hawkish, citing slight-to-moderate growth and higher inflation; John Williams said no rate change is needed. Traders priced a 3% chance of a 25 bp hike.

$AVGOMed

S&P Futures Muted as Fresh U.S.-Iran Hostilities Lift Oil and Bond Yields, ADP Jobs Report and Broadcom Earnings on Tap

S&P 500 futures were muted as U.S. JOLTS job openings rose to 7.618M in April, above expectations, while oil and bond yields moved higher amid fresh U.S.-Iran tensions. Cleveland Fed President Beth Hammack said rates should stay unchanged for now. Investors awaited ADP jobs, ISM services, factory orders, and EIA crude inventories; 10-year Treasury yield was 4.49%.

$VEEVMed

Veeva (VEEV) Q1 2027 Earnings Call Transcript

Veeva reported fiscal Q1 2027 revenue of $883 million and non-GAAP operating income of $395 million, both above internal guidance, according to management. Professional services hit a record quarter, driven by R&D and consulting. Commercial subscription guidance rose $15 million for the year, including $10 million from the Ostro acquisition. Veeva also discussed early rollout of AI “Falcon” and ongoing Vault CRM migrations.

$ONMed

Stocks Push Higher on US Labor Market Strength and AI Spending

US stocks rose as investors weighed strong labor-market data and ongoing AI spending, despite hawkish remarks from Cleveland Fed President Beth Hammack that the policy rate “may not be restrictive” and could need tightening if inflation stays elevated. Markets priced only a ~1% chance of a +25 bp Fed hike at June 16-17. Q1: 84% of 485 S&P 500 firms beat estimates; earnings seen +12% y/y.